Swiss startup Alithea Genomics raises about €972k to scale up innovative RNA-seq technology

Published on May 25, 2022

Committed to developing solutions that simplify and streamline the foundations of medical research, Alithea Genomics has just raised about €972k in fresh funding. The capital injection was led by the Novalis Biotech Acceleration fund, with the participation of Swiss-based private investors.  It has been said that today’s research is tomorrow’s medicine. Across the whole spectrum…

This content is for members only. Visit the site and log in/register to read.

The post Swiss startup Alithea Genomics raises about €972k to scale up innovative RNA-seq technology appeared first on EU-Startups.

Continue reading on website
Other news

London-based Flexa lands €2.7 million to bring transparency to the increasingly competitive global hiring market

May 25, 2022
The recruitment and hiring market is more competitive than ever before, and employees are demanding more respect and transparency throughout the process. The ways we work, right across the world, have drastically changed in a relatively short period of time and businesses need to keep up in order to continue to attract the best talent. … This content is for members only. Visit the site and log in/

Egyptian health and wellness platform Esaal raises $1.7M to scale across MENA

May 25, 2022
There’s a vast unmet demand for medical consultation in developing markets like Egypt due to low doctor supply. As of 2018, Egypt’s doctor to citizen ratio stood at 1:2,000; you can paint a picture when you walk into any government hospital and see long queues.These problems and pandemic-changing habits have resulted in an uptake in doctor-booking and consultation apps across Egypt and the wider M